Opko Health reported $-10739000 in Operating Profit for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Operating Profit Change
Abbott ABT:US $ 2388M 524M
Acadia Pharmaceuticals ACAD:US $ -33.65M 79.36M
Acorda Therapeutics ACOR:US $ -13.92M 2.79M
Agios Pharmaceuticals AGIO:US $ -94.94M 3.5M
Akebia Therapeutics AKBA:US $ 52.5M 111M
ALKERMES ALKS:US -34457000 7.87M
Alnylam Pharmaceuticals ALNY:US $ -191.69M 44.95M
Amarin AMRN:US $ -62.83M 34.52M
Arrowhead Research ARWR:US $ -72909000 114.46M
Biomarin Pharmaceutical BMRN:US $ 39.15M 98.18M
Bluebird Bio BLUE:US $ -107.4M 12.95M
Bristol Myers Squibb BMY:US $ 2590M 37M
Coherus Biosciences CHRS:US $ -44.01M 43.13M
Emergent Biosolutions EBS:US $ -72M 78.4M
Esperion Therapeutics ESPR:US $ -52376000 9.39M
Exact Sciences EXAS:US $ -159.58M 17.4M
Exelixis EXEL:US $ 83.71M 0.46M
Halozyme Therapeutics HALO:US $ 34.06M 41.61M
Insmed INSM:US $ -88316000 1.52M
Intercept Pharmaceuticals ICPT:US $ -13.36M 3.09M
IONIS PHARMACEUT IONS:US $ -85.51M 28.01M
Ironwood Pharmaceuticals IRWD:US $ 55.66M 2.19M
Laboratory Of America LH:US $ 525.9M 162M
Lexicon Pharmaceuticals LXRX:US -24007000 627K
Moderna Inc MRNA:US 2.45B 1.78B
Neurocrine Biosciences NBIX:US $ -15.3M 18.4M
Opko Health OPK:US $ -10.74M 61.68M
Ptc Therapeutics PTCT:US $ -92.36M 5.84M
Puma Biotechnology PBYI:US $ 12M 12.77M
Quest Diagnostics DGX:US $ 388M 125M
Sarepta Therapeutics SRPT:US $ -211.13M 124.25M
Seattle Genetics SGEN:US $ -133.11M 0.06M
Teva Pharmaceutical Industries TEVA:US $ -949M 236M
Ultragenyx Pharmaceutical RARE:US $ -141.59M 4.96M
United Therapeutics UTHR:US $ 201.8M 84.5M
Vanda Pharmaceuticals VNDA:US $ 3.46M 11.13M